Processa Pharmaceuticals Inc (PCSA) — Strategic Asset Allocation Index
Processa Pharmaceuticals Inc (PCSA) has a Strategic Asset Allocation Index of 2.0% as of June 2023. Strategic assets (PP&E of $187.60K plus long-term investments of $-) total $187.60K, measured against net assets of $9.16 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Processa Pharmaceuticals Inc Strategic Asset Allocation Index (2017–2021)
This chart shows how Processa Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2017 to 2021. As of June 2023, the index stands at 2.0%, representing strategic assets of $187.60K against net assets of $9.16 Million USD. Explore cash efficiency ratio of Processa Pharmaceuticals Inc to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Processa Pharmaceuticals Inc (2017–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Processa Pharmaceuticals Inc from 2017 to 2021, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Processa Pharmaceuticals Inc worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.3% | $74.18K | $74.18K | $- | $25.49 Million | ▼ -0.4 pp |
| 2020 | 0.7% | $159.04K | $159.04K | $- | $22.94 Million | ▼ -2.2 pp |
| 2019 | 2.8% | $228.00K | $228.00K | $- | $8.01 Million | ▲ +2.7 pp |
| 2018 | 0.2% | $17.38K | $17.38K | $0.00 | $9.70 Million | ▼ -6.7 pp |
| 2017 | 6.9% | $25.82K | $25.82K | $0.00 | $373.16K | — |